GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Momenta Pharmaceuticals, Inc. (MNTA) [hlAlert]

Rating:
Buy MNTA
down 18.46 %

Momenta Pharmaceuticals, Inc. (MNTA) rated Buy with price target $29 by Stifel

Posted on: Friday,  Jun 19, 2015  8:25 AM ET by Stifel

Stifel rated Buy Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) on 06/19/2015, when the stock price was $24.80. Since
then, Momenta Pharmaceuticals, Inc. has lost 18.47% as of 01/25/2016's recent price of $20.22.
If you would have followed this Stifel's recommendation on MNTA, you would have lost 18.46% of your investment in 220 days.

Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the detailed structural analysis and design of complex sugars for the development of improved versions of existing drugs, the development of novel drugs and the discovery of new biological processes. Momenta is also utilizing its ability to sequence sugars to create technology-enabled generic products.

Stifel
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/19/2015 8:25 AM Buy
None
24.80 29.00
as of 8/27/2015
1 Week down  -8.42 %
1 Month down  -17.43 %
3 Months down  -18.46 %
1 YTD down  -18.46 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy